Market Closed -
Other stock markets
|
After market 02:01:25 pm | |||
3.95 EUR | 0.00% | 3.895 | -1.39% |
May. 15 | Aiforia Wins a Framework Agreement to Provide AI Solutions for Fimlab Laboratories in Finland | CI |
Apr. 24 | Aiforia Signs A Contract with A Veterinary Health Company in the US | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 135.5 | 83.42 | 90.57 | 102.7 | - | - |
Enterprise Value (EV) 1 | 135.5 | 61.41 | 81.55 | 106.6 | 116.3 | 102.7 |
P/E ratio | - | -7.88 x | -6.98 x | -8.98 x | -10.1 x | -15.2 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 139 x | 44.7 x | 37.8 x | 23.9 x | 12.7 x | 7.23 x |
EV / Revenue | 139 x | 32.9 x | 34 x | 24.8 x | 14.4 x | 7.23 x |
EV / EBITDA | - | -7.57 x | -8.41 x | -15.7 x | -26.4 x | -205 x |
EV / FCF | - | -3.9 x | -5.73 x | -9.6 x | -13.1 x | -17.1 x |
FCF Yield | - | -25.6% | -17.4% | -10.4% | -7.65% | -5.84% |
Price to Book | - | 2.85 x | 5.06 x | 16.5 x | -26.3 x | - |
Nbr of stocks (in thousands) | 25,966 | 25,827 | 25,951 | 26,001 | - | - |
Reference price 2 | 5.220 | 3.230 | 3.490 | 3.950 | 3.950 | 3.950 |
Announcement Date | 3/3/22 | 3/2/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | 0.974 | 1.868 | 2.398 | 4.3 | 8.1 | 14.2 |
EBITDA 1 | - | -8.108 | -9.699 | -6.8 | -4.4 | -0.5 |
EBIT 1 | - | -10.2 | -12.88 | -11.4 | -10.2 | -6.9 |
Operating Margin | - | -546.2% | -537.07% | -265.12% | -125.93% | -48.59% |
Earnings before Tax (EBT) 1 | - | -10.61 | -12.92 | -11.5 | -10.5 | -7.2 |
Net income 1 | -7.576 | -10.61 | -12.92 | -11.5 | -10.5 | -7.2 |
Net margin | -777.82% | -567.83% | -538.99% | -267.44% | -129.63% | -50.7% |
EPS 2 | - | -0.4100 | -0.5000 | -0.4400 | -0.3900 | -0.2600 |
Free Cash Flow 1 | - | -15.75 | -14.23 | -11.1 | -8.9 | -6 |
FCF margin | - | -843.2% | -593.45% | -258.14% | -109.88% | -42.25% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/3/22 | 3/2/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|
Net sales 1 | 0.733 | 1.135 | 0.92 | 1.438 | 2 | 2.3 |
EBITDA 1 | -3.51 | -4.597 | -4.749 | -4.616 | -3.5 | -3.4 |
EBIT 1 | -4.389 | -5.814 | -6.182 | -6.363 | -5.5 | -5.8 |
Operating Margin | -598.77% | -512.25% | -671.96% | -442.49% | -275% | -252.17% |
Earnings before Tax (EBT) 1 | -4.38 | -6.227 | -6.254 | -6.413 | -5.6 | -5.9 |
Net income 1 | -4.38 | -6.227 | -6.254 | -6.393 | -5.6 | -5.9 |
Net margin | -597.54% | -548.63% | -679.78% | -444.58% | -280% | -256.52% |
EPS 2 | -0.1700 | -0.2400 | -0.2400 | -0.2500 | -0.2100 | -0.2200 |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/25/22 | 3/2/23 | 8/25/23 | 3/7/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 3.9 | 13.6 | - |
Net Cash position 1 | - | 22 | 9.01 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | -0.5735 x | -3.091 x | - |
Free Cash Flow 1 | - | -15.8 | -14.2 | -11.1 | -8.9 | -6 |
ROE (net income / shareholders' equity) | - | -31.6% | -54.8% | -95% | -935% | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share 2 | - | 1.130 | 0.6900 | 0.2400 | -0.1500 | - |
Cash Flow per Share 2 | - | -0.3600 | - | -0.2400 | -0.1400 | - |
Capex 1 | - | 6.33 | 6.07 | 5.5 | 5.6 | 6.2 |
Capex / Sales | - | 339.03% | 253.17% | 127.91% | 69.14% | 43.66% |
Announcement Date | 3/3/22 | 3/2/23 | 3/7/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.18% | 111M | |
+13.64% | 3,200B | |
+14.58% | 87.43B | |
+8.95% | 79.69B | |
-11.45% | 56.79B | |
+21.40% | 47.14B | |
+29.16% | 46.62B | |
-26.97% | 45.5B | |
+74.86% | 42.31B | |
-5.50% | 25.81B |
- Stock Market
- Equities
- AIFORIA Stock
- Financials Aiforia Technologies Oyj